Filter
38
Filtered Results: 38
Text search:
National
Drug
Authority
(NDA),
Uganda
Featured
Recommendations
4
New Publications
22
Language
Document type
No document type
31
Studies & Reports
4
Guidelines
2
Strategic & Response Plan
1
Countries / Regions
Uganda
32
Kenya
2
Rwanda
1
Sudan
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Policies
14
Drugs & Medical Equipment
14
Guidelines
5
Women & Child Health
2
Studies & Reports
2
Policies & Guidelines HIV & TB
1
Capacity Building
1
Disease Prevention & Control
1
Toolboxes
Country specific
2
Behaviour Change/Life Skill Education
1
HIV
1
TB
1
Essential Medicines
1
Essential Medicines & Devices Lists
1
Prices and Patents
1
Waste Managment
1
Reports & Studies
1
Children's Rights
1
Drug resistant TB
1
Research & Access
1
Uganda
1
Overview & Statistics
1
Background paper prepared for theEducation for All Global Monitoring Report 2012 Youth and skills: Putting education to work
2012/ED/EFA/MRT/PI/15
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
In the last five years, i.e. how old turned the Campaign “Indifesa” (Defenceless) in 2016, that was launched by Terre des Hommes in 2012, the world has become smaller. One can actually say that the derangements following the Arab Spring in 2011 reshuffled what is stable and what produces instabi...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
The Ministry of Health has developed the first version of the Service Standards and Service Delivery Standards for the health sector in Uganda. The main objective is to provide a common understanding of what is expected by the public, service users and service providers in ensuring provision of cons...
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
